Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into… byPallavi MadhirajuDecember 17, 2024